Depomed Inc (NASDAQ:DEPO)

22.41
Delayed Data
As of Mar 31
 -0.42 / -1.84%
Today’s Change
9.85
Today|||52-Week Range
25.54
+39.11%
Year-to-Date
No recent news for Depomed Inc.

Today’s Trading

Previous close22.83
Today’s open22.76
Day’s range-- - --
Volume828,183
Average volume (3 months)1,445,528
Market cap$1.4B
Dividend yield--
Data as of 03/31/2015

Growth & Valuation

Earnings growth (last year)+173.33%
Earnings growth (this year)-104.63%
Earnings growth (next 5 years)+72.00%
Revenue growth (last year)+190.87%
P/E ratio11.3
Price/Sales2.41
Price/Book3.71

Competitors

 Today’s
change
Today’s
% change
NEPTNeptune Technologies...-0.04-2.41%
VBLTVascular Biogenics L...-0.09-1.70%
TEVATeva Pharmaceutical-0.22-0.35%
Data as of 03/31/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$390.4M
Annual profit (last year)$131.8M
Net profit margin33.75%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
James A. Schoeneck
CFO, Senior VP &
Head-Investor Relations
August J. Moretti
Corporate headquarters
Newark, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account